LSD and the Future of Medicine

Date TBD | The past, present and future of LSD is happening in Switzerland. UZH continues this legacy being on the cutting edge of this field leading the charge and breaking long held taboos about treating mental health issues.

Event Details






Given the current status of COVID-19 this incredible panel, which was set to take place this weekend at SXSW, has had to be temporarily cancelled. We are currently in the process of seeking new avenues to bring you this amazing presentation and will continue to have updates so be sure to check back in and follow or social media.


Dr. Katrin Preller (University of Zurich) is in the midst of conducting the first-ever large scale controlled research study on the use of psychedelics for the treatment of depression and alcoholism. She and her colleagues believe that substances like LSD and psilocybin (“magic mushrooms”) not only present strong medical potential but could catalyze a paradigm shift in the way we approach mental health treatment entirely.

Be the first to hear from Katrin about some of the early experiences and results from this ongoing study, along with the personal experiences of Dr. Candace Lewis (TGen), who has herself directly experienced the treatment. This exploratory discussion will be moderated by Shannon Odell (The Science Channel), comedian, neuroscientist, and host of “Your Brain on Blank.”



Katrin Preller
Senior Research Fellow/Assistant Professor Adjunct
University of Zurich

Katrin Preller, Ph.D., received her M.Sc. (Neuropsychology) from University of Konstanz, Germany. For her PhD she went to University of Zurich, Switzerland, where she ran several studies investigating the neurobiological and social-cognitive long-term effects of cocaine, MDMA, and heroin use. After completing her PhD, she joined the Neuropsychopharmacology and Brain Imaging lab at the Psychiatric University Hospital Zurich, investigating the effects of psilocybin and LSD on self-perception, social cognition, and multimodal processing using different brain imaging techniques. After working as a postdoc at the Wellcome Trust Centre for Neuroimaging, UCL, London, UK, and Yale University, New Haven, CT, USA, she now continues her research on the neurobiological and clinical effects of psychedelics at University of Zurich and Yale University.


Candace Lewis

Candace Lewis
Post-Doctoral Fellow
Translational Genomics Research Institute

Dr. Lewis aims to revolutionize mental health and wellness by exploring dynamic environmental and genetic influences on brain-behavior relationships. A native of Alaska, she earned a Bachelor’s degree in Psychology from the University of Alaska Anchorage. Next, she earned a Ph.D. in Behavioral Neuroscience at Arizona State University on a Harry S. Truman Scholarship while investigating the effects of early life stress on addiction behavior and neuroepigenetics. Dr. Lewis received a Fulbright Fellowship to learn advanced neuroimaging and psychedelic research methods at the University Hospital of Zurich. She was also awarded the Science Foundation Arizona Bisgrove Fellowship to investigate the interplay between early experiences, epigenetics, physiology, and behavior. Taken together, her research centers around the age-old question of nature versus nurture with a modern twist. Dr. Lewis seeks to unravel how genetics and experiences continuously interact to shape neurobiology and behavior



Shannon Odell, PhD

Shannon Odell
PhD in Neuroscience
Weill Cornell Medicine

Shannon Odell is a Brooklyn based writer, comedian, and scientist. She co-hosts and produces Drunk Science, an experimental comedy show deemed “a stroke of genius” by Gothamist and a finalist in TruTV’s comedy break out initiative. She co-created, writes, and stars in the Inverse original series Your Brain on Blank, where she explains the science behind how everything-from alcohol to caffeine to puppies- affects the brain. She can also be seen at Weill Cornell Medicine, where she recently completed her PhD in neuroscience studying epigenetics and memory.